VFM
SLS icon

Vision Financial Markets’s SELLAS Life Sciences SLS Stock Holding History

Vision Financial Markets’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$145K Sell
9,800
-294,600
-97% -$2.03M 0.13% 90
2026
Q1 		$1.29M Buy
+304,400
New +$1.36M 1.26% 15

Other funds holding SLS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Jones Financial Companies
Jones Financial Companies Des Peres, Missouri $250B AUM 21.32% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Vision Financial Markets's SLS Position: Q2 2026 in Review

Vision Financial Markets reduced its SELLAS Life Sciences (SLS) stake by 97% in Q2 2026, selling an estimated $2.03M and leaving 9,800 shares worth $145K. The position accounts for 0.13% of the portfolio, ranked #90.

Vision Financial Markets first reported a position in SLS in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.29M in Q1 2026. 193 funds tracked by Wall St. Rank hold SLS as of Q2 2026.

  • Vision Financial Markets held 9,800 shares of SELLAS Life Sciences worth $145K as of Q2 2026.
  • Vision Financial Markets sold 294,600 SELLAS Life Sciences shares in Q2 2026, an estimated $2.03M.
  • SELLAS Life Sciences made up 0.13% of Vision Financial Markets's portfolio in Q2 2026, its #90 holding.
  • Vision Financial Markets first reported a position in SELLAS Life Sciences in Q1 2026 and has held it in 2 quarters since.
  • Vision Financial Markets's SELLAS Life Sciences position peaked at $1.29M in Q1 2026.
  • 193 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2026.

Based on Vision Financial Markets's 13F filing for Q2 2026, filed 24 Jul 2026.